Efficacy of Stellate Ganglion Block in Children With Autistic Disorder
Launched by ZENG CHANGHAO · Jan 19, 2024
Trial Information
Current as of July 04, 2025
Withdrawn
Keywords
ClinConnect Summary
Autistic Disorder in children is becoming increasingly more. The goal of this clinical trial is to explore efficacy of stellate ganglion block Children with Autistic Disorder. The main question it aims to answer is:
Can stellate ganglion block improve the Autistic Disorder in children? Children with Autistic Disorder will be divided into the control group and experimental group evenly. All the patients were provided with routine therapy, while the patients in the experimental group were given stellate ganglion block. The Childhood Autism Rating Scale of the two groups of patients before an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as Autistic Disorder.
- • Aged between 6 years old and 12 years old.
- • No contraindications to stellate ganglion block.
- Exclusion Criteria:
- • Other significant physical or neurodevelopmental disorders.
- • Other significant medical conditions
About Zeng Changhao
Zeng Changhao is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous and ethically conducted clinical studies. With a commitment to improving patient outcomes, Zeng Changhao collaborates with leading healthcare professionals and research institutions to explore novel therapies and treatment modalities. The organization emphasizes transparency, compliance, and patient safety, ensuring that all trials adhere to the highest regulatory standards. Through its strategic partnerships and a patient-centric approach, Zeng Changhao aims to contribute significantly to the development of effective and safe healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Zhengzhou, Henan, China
Patients applied
Trial Officials
Nieto Luis, Master
Study Chair
Site Coordinator of United Medical Group located in Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported